MET and prostate carcinoma: For example, high-Met-expressing DU145 prostate cancer cells showed concentration-dependent responses to HGF, with increased cell motility in both scatter and invasion assays, whereas PC3 cells (with equally high levels of Met expression) did not respond under the same conditions [28].